Immune response in the absence of neurovirulence in mice infected with m protein mutant vesicular stomatitis virus.
about
Potential of vesicular stomatitis virus as an oncolytic therapy for recurrent and drug-resistant ovarian cancer.Protection against lethal vaccinia virus challenge by using an attenuated matrix protein mutant vesicular stomatitis virus vaccine vector expressing poxvirus antigens.Induction of interferon and interferon signaling pathways by replication of defective interfering particle RNA in cells constitutively expressing vesicular stomatitis virus replication proteinsSafety studies on intrahepatic or intratumoral injection of oncolytic vesicular stomatitis virus expressing interferon-beta in rodents and nonhuman primatesInterplay between innate immunity and negative-strand RNA viruses: towards a rational modelStimulation of human dendritic cells by wild-type and M protein mutant vesicular stomatitis viruses engineered to express bacterial flagellin.Comparison of Heterologous Prime-Boost Strategies against Human Immunodeficiency Virus Type 1 Gag Using Negative Stranded RNA VirusesChanges in Susceptibility to Oncolytic Vesicular Stomatitis Virus during Progression of Prostate Cancer.Creation of matrix protein gene variants of two serotypes of vesicular stomatitis virus as prime-boost vaccine vectorsThe immune response to a vesicular stomatitis virus vaccine vector is independent of particulate antigen secretion and protein turnover rate.Protective efficacy of a recombinant Newcastle disease virus expressing glycoprotein of vesicular stomatitis virus in miceSusceptibility of breast cancer cells to an oncolytic matrix (M) protein mutant of vesicular stomatitis virus.Oncolytic vesicular stomatitis virus in an immunocompetent model of MUC1-positive or MUC1-null pancreatic ductal adenocarcinoma.Oncolytic vesicular stomatitis virus as a treatment for neuroendocrine tumors.Biomarkers in Japanese encephalitis: a review.Molecular determinants of susceptibility to oncolytic vesicular stomatitis virus in pancreatic adenocarcinoma.Heat shock protein 70 enhances mucosal immunity against human norovirus when coexpressed from a vesicular stomatitis virus vector.Overcoming cancer cell resistance to VSV oncolysis with JAK1/2 inhibitorsResistance of pancreatic cancer cells to oncolytic vesicular stomatitis virus: role of type I interferon signaling.Vesicular stomatitis virus as an oncolytic agent against pancreatic ductal adenocarcinoma.Peripheral immunization blocks lethal actions of vesicular stomatitis virus within the brain.Evaluation of vesicular stomatitis virus mutant as an oncolytic agent against prostate cancer.Signaling pathways in murine dendritic cells that regulate the response to vesicular stomatitis virus vectors that express flagellin.Preservation of dendritic cell function during vesicular stomatitis virus infection reflects both intrinsic and acquired mechanisms of resistance to suppression of host gene expression by viral M protein.Activating Peripheral Innate Immunity Enables Safe and Effective Oncolytic Virotherapy in the Brain.Vesicular stomatitis virus M protein mutant stimulates maturation of Toll-like receptor 7 (TLR7)-positive dendritic cells through TLR-dependent and -independent mechanisms.Immunogenicity in African Green Monkeys of M Protein Mutant Vesicular Stomatitis Virus Vectors and Contribution of Vector-Encoded Flagellin.Immunogenicity of propagation-restricted vesicular stomatitis virus encoding Ebola virus glycoprotein in guinea pigsJapanese Encephalitis Virus Generated Neurovirulence, Antigenicity, and Host Immune Responses
P2860
Q33579385-901992DA-369D-43E5-8844-5BCF24956306Q33725635-194311F7-9CA4-458A-93F4-C43EB0C5CB84Q33826779-E1BDF5D0-1F00-457B-A8E7-644A3E45B3CCQ33832168-E19605D6-A7BA-4BC8-996B-AD9B10719BA3Q34212787-FED87B5A-06EF-40AE-9005-F66ADFE12AA8Q34296055-8D451A58-DCD8-4E83-BA63-B1BD7D7147C1Q34806497-44BC5944-2B9E-4B7A-975D-9D5348777F93Q35641491-785700D6-A5F5-4510-A3BC-CA930135EBD7Q35760520-841AB242-06DA-43CF-B966-181B5BEF19DFQ35867988-6A0BD66B-4EF0-4B54-8E23-E7EF0D2CB9D1Q36611663-0C11562D-C860-496D-9ACD-70B53414863EQ36928622-EC0C0CA7-5664-4A7D-97F9-AD915181F70BQ37123143-EDF8DF35-1B29-4B38-BDD2-B9E97BD68A80Q37325067-301B3D31-A38E-45DE-B7ED-47CD5009DAAEQ37425963-718FD1C3-5CC1-4F65-B823-271EE16DC146Q37646792-B4F06C1E-C056-4B69-ADF4-AEC0BFF48D35Q37713979-FEC790E7-0817-4A04-A530-9C2CC618B1B5Q39096636-9D4BBB4E-67E6-415D-BFED-B05C0B753BB2Q39224943-BF7C6713-0EA3-4916-B8E2-CF3EE3B234A9Q39413447-CE7B5D09-330D-40C3-8A2E-374EBAD4E170Q39804428-026BEC04-FE11-49A7-BAAA-900CBB2EBA9BQ41379521-B9B542F4-0EF0-4976-B572-4AD952D9917EQ41820076-5C2F6086-9CDE-4284-89DA-91D92E9227FBQ42273541-00EEE79A-8DDA-4C59-981E-7F344F6FDF57Q42795549-C1E2FEAD-EF2F-4D79-A7B0-1A195A6CA753Q43163173-43FA3356-6BC6-4ABA-921E-680C46BEA00FQ53699705-D811FB3A-43F4-4B7B-9B75-B299BD95158EQ57197569-B2D4AB66-ED98-48FA-882A-3C420C87116EQ58999704-3CAD6ED7-BCF7-42AA-B009-95B12F5CE06F
P2860
Immune response in the absence of neurovirulence in mice infected with m protein mutant vesicular stomatitis virus.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Immune response in the absence ...... nt vesicular stomatitis virus.
@en
type
label
Immune response in the absence ...... nt vesicular stomatitis virus.
@en
prefLabel
Immune response in the absence ...... nt vesicular stomatitis virus.
@en
P2093
P2860
P356
P1433
P1476
Immune response in the absence ...... nt vesicular stomatitis virus.
@en
P2093
Douglas S Lyles
Maryam Ahmed
Nancy D Kock
Shelby Puckett
Tracie R Marino
P2860
P304
P356
10.1128/JVI.00915-08
P407
P577
2008-07-09T00:00:00Z